The use of antidepressants in irritable bowel syndrome

Practical Gastroenterology

Volumn 26, Issue 3, 2002, Pages 13-27

  Budavari, Adriane I ^a   Olden, Kevin W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ANALGESIA; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IRRITABLE COLON; NEUROMODULATION; PATHOPHYSIOLOGY; PSYCHOSOCIAL DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; STRESS; TREATMENT PLANNING;

EID: 0036202369     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact
2. Medical costs in community subjects with irritable bowel syndrome
3. Patients with irritable bowel syndrome: Health status and use of health care services
4. Irritable bowel, irritable body or irritable brain
5. Survey of the AGA membership relating to patients with functional gastrointestinal disorders
6. Irritable bowel syndrome in office-based practice in the United States
7. Intestinal motor function in irritable bowel syndrome
8. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and non-painful rectal distension
9. Dysfunction of the motivational-affective pain system in patients with IBS: PET brain imaging in response to rectal balloon distension
10. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome
11. Effects of inflammatory mediators on gut sensitivity
12. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: A pilot study
13. 5-Hydroxytryptamine and enterochromaffin cells in the irritable bowel syndrome
14. Terminal ileal mucosal mast cells in irritable bowel syndrome
15. Psychologic and psychiatric aspects of gastrointestinal disease
16. Psychosocial aspects of the functional gastrointestinal disorders
17. Irritable bowel syndrome-post-salmonella infection
18. The role of psychological and biological factors in postinfective gut dysfunction
19. Irritable bowel syndrome: The influence of psychological factors on the symptom complex
20. Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and nonpatients with irritable bowel syndrome
21. Medical and psychiatric symptoms in female gastroenterology clinic patients with histories of sexual victimization
22. Sexual and physical abuse history in gastroenterology practice: How types of abuse impact health status
23. A five-year study on the interactive effects of depression and physical illness on psychiatric unit length of stay
24. Amitryptiline in the treatment of gastrointestinal disorders
25. Treatment of chronic tension headache
26. The relief of pain with an antidepressant in arthritis
27. Antidepressants in the management of chronic pain syndromes
28. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies
29. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans
30. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis
31. Controlled treatment trials in the irritable bowel syndrome: A critique
32. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials
33. Treatment of irritable bowel syndrome: A review of randomised controlled trials
34. Irritable colon and depression
35. Therapeutic usefulness of amitriptyline in spastic colon syndrome
36. The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study
37. Evaluation of tricyclic compund (Trimipramine) vis-à-vis placebo in irritable bowel syndrome. Double blind randomized study
38. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome
39. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo
40. Effect of antidepressant drug (doxepin) on irritable bowel syndrome patients
41. Irritable bowel syndrome: Symptom relief with amitriptyline in the irritable bowel syndrome
42. Effect sizes for interpreting changes in health status
43. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
44. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome
45. Effect of a tricyclic antidepressant on small intestinal motility in health and in diarrhea-predominant irritable bowel syndrome
46. Cost-effective randomised controlled trial of psychotherapy and antidepressants for severe irritable bowel syndrome
47. Antidepressants for functional gastrointestinal syndromes
48. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain
49. Refractory gastrointestinal symptoms: A combined medical psychiatric approach
50. Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms
51. Deign of treatment trials for the functional gastrointestinal disorders